Transposon Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2019-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.transposonrx.com
TPN-101 in Aicardi-Goutières Syndrome (AGS)
- First Posted Date
- 2022-11-14
- Last Posted Date
- 2025-04-04
- Lead Sponsor
- Transposon Therapeutics, Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT05613868
- Locations
- 🇫🇷
Laboratory of Neurogenetics and Neuroinflammation Imagine Institute - INSERM U1163, Paris, France
🇮🇹Presidio Ospedale dei Bambini [Children's Hospital], Brescia, Italy
🇮🇹SST Fatebenefratelli Sacco, Milano, Italy
A Phase 2a Study of TPN-101 in Patients With Progressive Supranuclear Palsy (PSP)
Phase 2
Active, not recruiting
- Conditions
- Progressive Supranuclear Palsy
- Interventions
- Drug: TPN-101, 200 mg/dayDrug: TPN-101, 100 mg/dayDrug: TPN-101, 400 mg/dayDrug: Placebo
- First Posted Date
- 2021-08-06
- Last Posted Date
- 2023-07-13
- Lead Sponsor
- Transposon Therapeutics, Inc.
- Target Recruit Count
- 40
- Registration Number
- NCT04993768
- Locations
- 🇺🇸
Irving Center for Clinical and Translational Research, New York, New York, United States
🇺🇸Rocky Mountain Movement Disorders Center, Englewood, Colorado, United States
🇺🇸Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton, Florida, United States
A Phase 2a Study of TPN-101 in Patients With C9ORF72 ALS/FTD
Phase 2
Active, not recruiting
- Conditions
- Amyotrophic Lateral SclerosisFrontotemporal Dementia
- Interventions
- Drug: TPN-101, 400 mg/dayDrug: Placebo
- First Posted Date
- 2021-08-06
- Last Posted Date
- 2023-03-06
- Lead Sponsor
- Transposon Therapeutics, Inc.
- Target Recruit Count
- 42
- Registration Number
- NCT04993755
- Locations
- 🇺🇸
Massachusetts General Hospital (MGH) - Amyotrophic Lateral Sclerosis (ALS) Multidisciplinary Clinic, Boston, Massachusetts, United States
🇺🇸John Hopkins University, Baltimore, Maryland, United States
🇫🇷CHU Dupuytren, Limoges, Limoges, France
© Copyright 2025. All Rights Reserved by MedPath